FDA Adverse Event Malfunction Summary report: N

UNIFY ASSURA CRT-D RF HV

MDR report key: 8466407 · Received March 29, 2019

Report

Report Number
2017865-2019-04688
Event Type
Malfunction
Date Received
March 29, 2019
Date of Event
March 16, 2019
Report Date
May 27, 2019
Manufacturer
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
Product Code
LWS
UDI-DI
05414734508216
PMA / PMN Number
P910023
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

FURTHER INFORMATION WAS REQUESTED BUT NOT RECEIVED. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.

Additional Manufacturer Narrative · 1

CORRECTION: SERIAL # SHOULD BE (B)(6) NOT (B)(4) , MODEL # SHOULD BE CD3369-40C NOT CD3357-40Q, LOT # , EXPIRATION DATE, UDI UPDATED. DEVICE MANUFACTURING DATE UPDATED MAR 8, 2017. PMA UPDATED SHOULD BE P910023.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT PRESENTED REMOTELY VIA MERLIN.NET. IT WAS NOTED THAT RIGHT VENTRICULAR OVERSENSING WAS OBSERVED ON THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR. THE PATIENT WAS STABLE.

Description of Event or Problem · 1

RELATED MANUFACTURER REFERENCE NUMBER: 2017865-2019-05882. NEW INFORMATION RECEIVED NOTES THAT INTERROGATION OF THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN CLINIC REVEALED THAT THE LEFT VENTRICULAR VECTOR HAD A HIGH CAPTURE THRESHOLD AND INTERMITTENT CAPTURE. MICRODISLODGEMENT OF THE LEFT VENTRICULAR LEAD WAS SUSPECTED. PROGRAMMING CHANGES WERE MADE. THE PATIENT WAS STABLE.

Description of Event or Problem · 1

NEW INFORMATION NOTES SERIAL NUMBER SHOULD BE (B)(4) NOT (B)(4). INFORMATION UPDATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
256460 UNIFY ASSURA CRT-D RF HV IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS ST. JUDE MEDICAL, INC.(CRM-SYLMAR) CD3369-40C A000037000 05414734508216

Patients

Seq Age Sex Outcome Treatment
1 69 YR